Novocure (NVCR) Tops Q3 EPS by 4c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $43.55 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
• Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'